Tumor Microenvironment
A section of Cancers (ISSN 2072-6694).
Section Information
The MDPI journal Cancers has recently defined the scope and have introduced a Tumor Microenvironment Section. The TME section aims to publish high-quality research on the molecular and cellular components of cancer microenvironment, with a particular focus on basic, translational and clinical research that has significant implications for the diagnosis, prevention and treatment of human malignancies. The subject area include, but not limited to, the mechanisms playing essential role in tumor cell plasticity under the influence of unique microenvironment, molecular and cellular markers for diagnosis, prognosis, drug targets in malignant cells and its microenvironment, and the role of microbiome in influencing the etiology and characteristics of cancer cell. The section also encourages communication of scientific advancement in complementary and alternative medicines influencing tumor microenvironment.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Recent Perspectives on Mechanisms of Radiation-Mediated DNA Damage Induction and Response in Cancers (Deadline: 31 March 2024)
- Targeting Signal Transduction Pathways in Cancer (Deadline: 31 March 2024)
- Heat Shock Proteins in Cancers (Deadline: 31 March 2024)
- Tumor-Associated Microenvironments and Inflammation (Deadline: 15 April 2024)
- Regulation of HIFs in Cancer Cells (Deadline: 30 April 2024)
- Emerging Therapeutic Approaches for Gastrointestinal Malignancies and the Tumour Microenvironment (Deadline: 30 April 2024)
- The Extracellular Matrix in Cancer Ecosystems: Functional Contributions and Targeting Opportunities (Deadline: 30 April 2024)
- Circulating Tumor Cells (CTCs): Current and Emerging Utility in Cancer (Deadline: 30 April 2024)
- Revolutionizing Cancer Therapy: Unleashing the Power of MET Inhibitors (Deadline: 30 April 2024)
- Cell Death in Gynecologic Cancers (Deadline: 30 April 2024)
- Molecular Aspects of Tumor Microenvironment of Acute Myeloid Leukemia (Deadline: 1 May 2024)
- Microbiomes and Modulation of Therapeutic Responses in Cancer (Deadline: 15 May 2024)
- Advances in Head and Neck Cancer Research (Deadline: 20 May 2024)
- Tumor Microenvironment of Breast Cancer (Deadline: 25 May 2024)
- Imaging the Tumor Microenvironment (Deadline: 31 May 2024)
- Tumor Microenvironment and Treatment Resistance (Deadline: 31 May 2024)
- Seminal Discoveries Relating to Chromatin Remodeling and Its Regulation of Cancer Biology (Deadline: 31 May 2024)
- Role of Cytokines in Cancer (Deadline: 31 May 2024)
- Advances in Acidosis within the Tumor Microenvironment (Deadline: 31 May 2024)
- Pathway in Breast Cancer (Deadline: 31 May 2024)
- Ovarian Cancer Stem Cells and Tumor Microenvironment (Deadline: 31 May 2024)
- The New Challenge of Curing AML: Analysis of Mechanisms of Resistance of Target Drugs and Future Perspectives (Deadline: 31 May 2024)
- Emerging Role of Exosomes in Comorbidity-Associated Cancer Progression (Deadline: 31 May 2024)
- Targeting the JAK–STAT Signaling Axis in Cancer (Deadline: 15 June 2024)
- Invasion in Glioblastoma (Deadline: 20 June 2024)
- Tumor Microenvironment in Primary Liver Cancer (Deadline: 28 June 2024)
- Targeting the Sphingolipid Metabolic Pathway: Promotion from Benchwarmer to the Starting Lineup—a Themed Issue in Memory of Dr’s. Lina Obeid and Mark Kester (Deadline: 30 June 2024)
- Circulating Tumor Cells: Origin, Fate, and Roles in Immune Evasion and Metastasis (Deadline: 30 June 2024)
- Inflammation and Metabolism of Cancers (Deadline: 30 June 2024)
- The Role of Tumor Microenvironment in Solid Tumors: Development of Cancer Research (Deadline: 30 June 2024)
- Neurofibromatosis Type 1 (NF1) Related Tumors (Deadline: 1 July 2024)
- The Tumor Microenvironment and Its Role in Tumor Growth and Angiogenesis (Deadline: 10 July 2024)
- The Role of Immunity in the Tumor Microenvironment (Deadline: 15 July 2024)
- Targeting TGF-β as a Marker and Pharmacological Target against Cancer (Deadline: 15 July 2024)
- Inhibitors in Chronic Myeloid Leukemia (Deadline: 16 July 2024)
- Targeting Tumor Microenvironment in Cancer: Promises and Challenges (Deadline: 20 July 2024)
- Targeting Metabolic Vulnerabilities in Cancer (Deadline: 30 July 2024)
- The Cancer Microenvironment and Its Impact on Cell Adhesion, Migration and Invasion (Deadline: 31 July 2024)
- Novel Therapeutic Targets for Ovarian Cancer (Deadline: 31 July 2024)
- Insights into Cancer Stem Cells (Deadline: 31 July 2024)
- Targeted Therapies for Cancer Metastasis (Deadline: 5 August 2024)
- Advances in Plasma Cell Dyscrasias (Deadline: 15 August 2024)
- Effects of Radiotherapy on the Tumor Microenvironment (Deadline: 15 August 2024)
- The Warburg Effect in Cancers (Deadline: 15 August 2024)
- State-of-the-Art Strategies for Non-coding RNA Function Detection and Regulation in Cancer (Deadline: 20 August 2024)
- Multi-Faceted Epigenetic Dysregulation in Acute Myeloid Leukemia (Deadline: 23 August 2024)
- Radiation Exposure, Inflammation and Cancers (Deadline: 25 August 2024)
- Signaling Pathways of Breast Cancer (Deadline: 30 August 2024)
- Targeting the Tumor Microenvironment (Volume II) (Deadline: 31 August 2024)
- Epigenetics of Prostate Cancer (Deadline: 31 August 2024)
- Extracellular Vesicles (EVs) in Cancer Diagnostics and Therapy (Deadline: 31 August 2024)
- Advances in Bacteria and Cancer (Deadline: 10 September 2024)
- Proteomic and Genomic Profiling of Pancreatic Cancer (Deadline: 15 September 2024)
- Unique Perspectives in Cancer Signaling (Deadline: 15 September 2024)
- Functional Neuro-Oncology—Volume II (Deadline: 15 September 2024)
- Advances in Chronic Lymphocytic Leukemia Microenvironment: The Disruption of the Supportive Leukemic/Accessory Cells Interactions to Improve Therapy Response (Deadline: 15 September 2024)
- Genome Instability and Human Cancer (Deadline: 15 September 2024)
- Microenvironment of Leukemia (Deadline: 20 September 2024)
- Treatment of Peripheral T-cell Lymphomas (Deadline: 30 September 2024)
- Lifestyle Choices and Endocrine Dysfunction on Cancer Onset and Risk (Deadline: 30 September 2024)
- Relationship between Protein and Metabolite in Cancers (Deadline: 25 October 2024)
- MicroRNA and Cancer Immunology (Deadline: 31 October 2024)
- Role of Extracellular Vesicles in Cancer Progression (Deadline: 31 October 2024)
- Recent Updates on Cancer Stem Cells and Tumor Microenvironment (Deadline: 31 October 2024)
- Epigenetic Regulation in Cancers (Deadline: 31 October 2024)
- Tumor Microenvironment: Intercellular Communication (Deadline: 1 November 2024)
- Aging and Cancers (Deadline: 15 November 2024)
- Extracellular Matrix Proteins in Cancer (Deadline: 15 November 2024)
- Aberrant Cytokine Receptor Signaling in Hematological Cancers and Proliferative Disorders (Deadline: 20 November 2024)
- Cytokines in Cancer Immunotherapy 2.0 (Deadline: 30 November 2024)
- Role of Autophagy in Cancer Stem Cells and the Tumor Microenvironment: New Frontiers in Cancer Drug Discovery (Deadline: 30 November 2024)
- New Molecular Targets and Emerging Approaches to Target Cancer Stem Cells (Deadline: 30 November 2024)
- Post-transcriptional Regulation of Cancer-Related Processes (Deadline: 1 December 2024)
- Latest Breakthroughs in Tumor Immune Microenvironment: From Cellular Discovery to Cutting-Edge Technology (Deadline: 5 December 2024)
- Tumor-Initiating Cells in Breast Cancer: From Bench to Bedside (Deadline: 15 December 2024)
- Autophagy–EMT Interrelations: At the Core of Tumor Transformation (Deadline: 20 December 2024)
- Tumor Immune Microenvironment in Gastric Cancers (Deadline: 25 December 2024)
- Oral Cancer and the Microbiome (Deadline: 31 December 2024)
- State-of-the-Art Treatment on Chemotherapy and Immunotherapy for Urological Cancer (Deadline: 31 December 2024)
- The Role of Autophagy in Brain Tumors (Volume II) (Deadline: 31 December 2024)
- Integrins and Tumor Microenvironment, New Perspectives in Targeted Treatments (Deadline: 31 December 2024)
- Advances in Chronic Lymphocytic Leukaemia (CLL) Research (Deadline: 31 December 2024)
- Non-coding RNAs in the Tumor Microenvironment (Deadline: 1 February 2025)
- Metabolic Adaptations in Cancer (Deadline: 25 February 2025)
- EVs and EPS in Cancer: Cell-to-Cell Communication, Diagnosis, and Evaluation of Cancer Therapy Response (Deadline: 20 July 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Deciphering the Crosstalk between Tumor Cells and Their Microenvironment: From Molecular Aspects to Therapeutic Implications
- Matrix Effectors and Cancer
- Molecular Signaling Pathways and Networks on Cancer
- New Discoveries and Future Trend for Prostate Cancer Research and Treatment
- Targeting Solid Tumors